Skip to main content

Oncology

A rare, late side effect of radiotherapy

Open Access Breast Cancer Case Study

A woman developed sudden painless ecchymosis (bruising) of her breast, which was thought to be related to the radiotherapy she received for early-stage breast cancer a year and a half earlier.

Antiepileptic strategies for patients with brain tumors

Epilepsy due to primary or metastatic brain tumors accounts for 6–10% of all cases of epilepsy. Levetiracetam monotherapy is the initial treatment of choice, but other pharmacologic and nonpharmacologic options are also available.

Pericardial effusion in cancer patients

Open Access Pericardial Disease Review

Cancer-related pericardial effusion can be due to the tumor itself or the treatment. Delve into the key aspects of diagnosing and managing the condition and get up-to-date practical guidance.

Successful management of ATO-induced acute pericarditis

Free for a limited time Acute Promyelocytic Leukemia Case Study

A patient receiving arsenic trioxide for acute promyelocytic leukemia developed drug-induced acute pericarditis that was successfully treated with colchicine.

Case-Based Insights: Oncology and Hematology


Refresh your knowledge in Oncology and Hematology: 

  • 45 clinical cases across different topics with relevant clinical images
  • Written by renowned experts 
  • Knowledge-check questions with answers
Try the first set of cases now

A rare, late side effect of radiotherapy

Open Access Breast Cancer Case Study

A woman developed sudden painless ecchymosis (bruising) of her breast, which was thought to be related to the radiotherapy she received for early-stage breast cancer a year and a half earlier.

Successful management of ATO-induced acute pericarditis

Free for a limited time Acute Promyelocytic Leukemia Case Study

A patient receiving arsenic trioxide for acute promyelocytic leukemia developed drug-induced acute pericarditis that was successfully treated with colchicine.

Rare example of a metastatic brain tumor infiltrating a meningioma

Open Access Meningioma Case Study

Tumor-to-tumor metastasis is the most common extracranial cancer metastasis to existing brain tumors, whereas a rare form is metastasis infiltrating tumor. In this case, a lung cancer tumor metastasized adjacent to and partially infiltrated an existing meningioma.

Current Reviews

Burning mouth in oncology care: a systematic review

Burning mouth, also referred to as oral dysesthesia, is an underreported condition among cancer patients that may represent an early symptom of cancer or an adverse effect of treatment. This review sought to characterize this symptom in oncology …

Efficacy of physical exercise intervention on children with acute lymphoblastic leukemia during treatment and rehabilitation: a systematic review and meta-analysis

Acute lymphoblastic leukemia (ALL) is a kind of malignant tumor disease with the main clinical characteristics of neutrophil, platelet reduction, and anemia [ 1 – 3 ], which can invade the bone marrow, blood, and other organs of the whole body [ 4 …

Tattooing to reconstruct Nipple-Areola Complex after oncological breast surgery: a scoping review

Open Access Breast Cancer Review

At the end of 2020, breast cancer was the most prevalent cancer in the world [ 1 ]. If the tumor position is found in the tissues below the areola or on the surrounding skin , Nipple-Areola Complex (NAC) removal may be necessary. This procedure can …

Immunogenic cell death in colorectal cancer: a review of mechanisms and clinical utility

Open Access Colorectal Cancer Review

Colorectal cancer (CRC) is a major cause of cancer-related morbidity and mortality worldwide. Despite several clinical advances the survival of patients with advanced colorectal cancer remains limited, demanding newer approaches. The immune system …

Webcast | Videos | Cases (Link opens in a new window)

Identifying molecular biomarkers is crucial in determining the best targeted treatment options for your patients with advanced thyroid cancer.

Join our expert-led multi-format educational program that explores the continuing discovery of new genomic targets and delivers the latest research in molecular testing and the application of targeted therapies for thyroid cancer.

Start by watching our webcast and short vodcasts.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME

eLearning | Interviews | Digital Treatment Map (Link opens in a new window)

1.0 AMA PRA Category 1 Credit(s)

Expert-led, multiformat program which will address the individualized management of NSCLC, through education on the detection of NTRK gene fusions, current evidence-based guidelines, and new and emerging therapies. Will also include guidance on integrating shared decision making into your clinical practice, drawing on insights from a patient on how best to communicate.

Supported by:
  • Bayer HealthCare Pharmaceuticals Inc.
Developed by: Springer Healthcare IME

eLearning | Interviews | Cases (Link opens in a new window)

0.75 AMA PRA Category 1 Credit(s)

Knowledge center focusing on improving the individualized management of HR+/HER2- early breast cancer.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Further Reading

Coverage for evidence-based cancer survivorship care services

Open Access Hodgkin Lymphoma Research

In 2006, the Institute of Medicine published a report titled “From Cancer Patient to Cancer Survivor.” This report describes the importance of providing comprehensive, coordinated care for cancer survivors [ 1 ]. The report highlighted the …

Targeting myeloperoxidase limits myeloid cell immunosuppression enhancing immune checkpoint therapy for pancreatic cancer

Open Access Pancreatic Cancer Research

Pancreatic ductal adenocarcinoma is a devastating disease characterized by an extreme resistance to current therapies, including immune checkpoint therapy. The limited success of immunotherapies can be attributed to a highly immunosuppressive …

Chemokine CCL21 determines immunotherapy response in hepatocellular carcinoma by affecting neutrophil polarization

Open Access Hepatocellular Carcinoma Research

Liver cancer is one of the leading causes of tumor-related deaths worldwide, with the sixth highest incidence and third highest mortality rate currently [ 1 ]. Over 90% cases of primary liver cancers are hepatocellular carcinomas (HCC), and life …

Induction immunotherapy plus chemotherapy followed by definitive chemoradiation therapy in locally advanced esophageal squamous cell carcinoma: a propensity-score matched study

Open Access Cytostatic Therapy Research

Esophageal cancer (EC) ranks as the sixth leading cause of cancer-related death worldwide, resulting in approximately 5.4 million deaths annually [ 1 , 2 ]. Substantial variations exist in the incidence, mortality, and histopathology of esophageal …

Related topics

Free for a limited time Acute Promyelocytic Leukemia Case Study

Successful management of ATO-induced acute pericarditis

A patient receiving arsenic trioxide for acute promyelocytic leukemia developed drug-induced acute pericarditis that was successfully treated with colchicine.

Read more
01-03-2024 Cervical Cancer News

Radical hysterectomy can be avoided in some cervical cancer patients

The SHAPE trial supports the use of simple rather than radical hysterectomy in selected patients with low-risk cervical cancer.

Read more